HK Stock MarketDetailed Quotes

02268 WUXI XDC

Watchlist
  • 31.350
  • -0.650-2.03%
Market Closed Dec 12 16:08 CST
37.61BMarket Cap57.73P/E (TTM)

WUXI XDC Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
Turnover
67.61%1.67B
114.44%2.12B
201.57%993.47M
301.56%487.59M
218.33%990.42M
--329.44M
--121.43M
222.91%311.13M
--96.35M
Operating income
67.61%1.67B
114.44%2.12B
201.57%993.47M
301.56%487.59M
218.33%990.42M
329.44M
121.43M
222.91%311.13M
96.35M
Cost of sales
-47.88%-1.13B
-114.48%-1.56B
-238.86%-764.07M
-389.90%-369.22M
-269.03%-729.34M
---225.48M
---75.37M
-123.90%-197.64M
---88.27M
Operating expenses
-47.88%-1.13B
-114.48%-1.56B
-238.86%-764.07M
-389.90%-369.22M
-269.03%-729.34M
-225.48M
-75.37M
-123.90%-197.64M
-88.27M
Gross profit
133.36%535.33M
114.32%559.56M
120.67%229.4M
157.01%118.38M
130.04%261.08M
103.96M
46.06M
1,304.45%113.49M
8.08M
Selling expenses
-310.91%-23.93M
-73.57%-15.22M
-40.25%-5.82M
-23.31%-2.15M
-332.40%-8.77M
---4.15M
---1.75M
-324.27%-2.03M
---478K
Administrative expenses
-76.72%-75.53M
-151.91%-123.97M
-180.29%-42.74M
-97.30%-16.32M
-76.65%-49.21M
---15.25M
---8.27M
-189.95%-27.86M
---9.61M
Research and development expenses
-59.99%-47.59M
-127.13%-76.87M
-169.00%-29.75M
-271.47%-16.25M
-144.97%-33.84M
---11.06M
---4.38M
-239.02%-13.82M
---4.08M
Impairment and provision
-112.99%-3.17M
150.71%21.99M
719.29%24.38M
166.79%15.39M
-310.77%-43.37M
--2.98M
--5.77M
-3,553.29%-10.56M
---289K
-Other impairment is provision
-112.99%-3.17M
150.71%21.99M
719.29%24.38M
166.79%15.39M
-310.77%-43.37M
--2.98M
--5.77M
-3,553.29%-10.56M
---289K
Special items of operating profit
382.33%176.85M
-107.06%-5.14M
-17.59%36.67M
-86.50%370K
797.84%72.82M
--44.49M
--2.74M
-79.06%8.11M
--38.74M
Operating profit
164.91%561.97M
81.34%360.35M
75.37%212.14M
147.44%99.41M
195.07%198.72M
120.96M
40.18M
108.08%67.35M
32.37M
Financing cost
56.24%-249K
74.55%-742K
63.83%-569K
10.11%-427K
-491.48%-2.92M
---1.57M
---475K
---493K
----
Earning before tax
165.50%561.72M
83.66%359.61M
77.21%211.57M
149.32%98.98M
192.88%195.8M
119.39M
39.7M
106.55%66.85M
32.37M
Tax
-113.91%-73.49M
-89.85%-76.07M
-62.64%-34.35M
-105.02%-18.31M
-236.07%-40.07M
---21.12M
---8.93M
-96.52%-11.92M
---6.07M
After-tax profit from continuing operations
175.50%488.23M
82.07%283.54M
80.34%177.21M
162.18%80.67M
183.51%155.73M
98.27M
30.77M
108.87%54.93M
26.3M
Earning after tax
175.50%488.23M
82.07%283.54M
80.34%177.21M
162.18%80.67M
183.51%155.73M
98.27M
30.77M
108.87%54.93M
26.3M
Profit attributable to shareholders
175.50%488.23M
82.07%283.54M
80.34%177.21M
162.18%80.67M
183.51%155.73M
98.27M
30.77M
108.87%54.93M
26.3M
Basic earnings per share
127.78%0.41
55.56%0.28
28.57%0.18
60.00%0.08
100.00%0.18
0.14
0.05
125.00%0.09
0.04
Diluted earnings per share
123.53%0.38
44.44%0.26
21.43%0.17
60.00%0.08
100.00%0.18
0.14
0.05
125.00%0.09
0.04
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified Opinion
--
--
Unqualified Opinion
--
--
Unqualified Opinion
Unqualified Opinion
Auditor
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
--
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
--
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
Deloitte Guan Huang Chen Fang Certified Public Accountants
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020
Turnover 67.61%1.67B114.44%2.12B201.57%993.47M301.56%487.59M218.33%990.42M--329.44M--121.43M222.91%311.13M--96.35M
Operating income 67.61%1.67B114.44%2.12B201.57%993.47M301.56%487.59M218.33%990.42M329.44M121.43M222.91%311.13M96.35M
Cost of sales -47.88%-1.13B-114.48%-1.56B-238.86%-764.07M-389.90%-369.22M-269.03%-729.34M---225.48M---75.37M-123.90%-197.64M---88.27M
Operating expenses -47.88%-1.13B-114.48%-1.56B-238.86%-764.07M-389.90%-369.22M-269.03%-729.34M-225.48M-75.37M-123.90%-197.64M-88.27M
Gross profit 133.36%535.33M114.32%559.56M120.67%229.4M157.01%118.38M130.04%261.08M103.96M46.06M1,304.45%113.49M8.08M
Selling expenses -310.91%-23.93M-73.57%-15.22M-40.25%-5.82M-23.31%-2.15M-332.40%-8.77M---4.15M---1.75M-324.27%-2.03M---478K
Administrative expenses -76.72%-75.53M-151.91%-123.97M-180.29%-42.74M-97.30%-16.32M-76.65%-49.21M---15.25M---8.27M-189.95%-27.86M---9.61M
Research and development expenses -59.99%-47.59M-127.13%-76.87M-169.00%-29.75M-271.47%-16.25M-144.97%-33.84M---11.06M---4.38M-239.02%-13.82M---4.08M
Impairment and provision -112.99%-3.17M150.71%21.99M719.29%24.38M166.79%15.39M-310.77%-43.37M--2.98M--5.77M-3,553.29%-10.56M---289K
-Other impairment is provision -112.99%-3.17M150.71%21.99M719.29%24.38M166.79%15.39M-310.77%-43.37M--2.98M--5.77M-3,553.29%-10.56M---289K
Special items of operating profit 382.33%176.85M-107.06%-5.14M-17.59%36.67M-86.50%370K797.84%72.82M--44.49M--2.74M-79.06%8.11M--38.74M
Operating profit 164.91%561.97M81.34%360.35M75.37%212.14M147.44%99.41M195.07%198.72M120.96M40.18M108.08%67.35M32.37M
Financing cost 56.24%-249K74.55%-742K63.83%-569K10.11%-427K-491.48%-2.92M---1.57M---475K---493K----
Earning before tax 165.50%561.72M83.66%359.61M77.21%211.57M149.32%98.98M192.88%195.8M119.39M39.7M106.55%66.85M32.37M
Tax -113.91%-73.49M-89.85%-76.07M-62.64%-34.35M-105.02%-18.31M-236.07%-40.07M---21.12M---8.93M-96.52%-11.92M---6.07M
After-tax profit from continuing operations 175.50%488.23M82.07%283.54M80.34%177.21M162.18%80.67M183.51%155.73M98.27M30.77M108.87%54.93M26.3M
Earning after tax 175.50%488.23M82.07%283.54M80.34%177.21M162.18%80.67M183.51%155.73M98.27M30.77M108.87%54.93M26.3M
Profit attributable to shareholders 175.50%488.23M82.07%283.54M80.34%177.21M162.18%80.67M183.51%155.73M98.27M30.77M108.87%54.93M26.3M
Basic earnings per share 127.78%0.4155.56%0.2828.57%0.1860.00%0.08100.00%0.180.140.05125.00%0.090.04
Diluted earnings per share 123.53%0.3844.44%0.2621.43%0.1760.00%0.08100.00%0.180.140.05125.00%0.090.04
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIAS
Audit Opinions --Unqualified Opinion----Unqualified Opinion----Unqualified OpinionUnqualified Opinion
Auditor --Deloitte Guan Huang Chen Fang Certified Public Accountants----Deloitte Guan Huang Chen Fang Certified Public Accountants----Deloitte Guan Huang Chen Fang Certified Public AccountantsDeloitte Guan Huang Chen Fang Certified Public Accountants

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
HK
Overall
Symbol
Price
% Chg

No Data

Investment Theme Biotechnology
Biotechnology
Intraday-1.09%